CLINICAL_TRIALS
trial_result
· 2014-07-16
Clinical Trial Update: NasoNeb Delivery of an Intranasal Steroid [Phase 4]
Summary
Phase 4 trial results update for NasoNeb-delivered intranasal steroid in perennial allergic rhinitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Chicago | Conditions: Perennial Allergic Rhinitis | Phase 4 | Status: COMPLETED | Results posted: 2014-07-16